Testing novel compound EMS2CH2 on tamoxifen resistant estrogen receptor positive (ER+) breast cancer cells and their targeted kill rates.
Presentation
- Overview
Overview
Date/time Interval
- 2019-04-01
Occurs Within Event
Participant
- Frampton, Arthur Ronald Presenter 2019-04-01